開能健康(300272.SZ):直銷模式以“開能”牌整機設備為主
格隆匯11月17日丨開能健康(300272.SZ)近期在接待機構投資者調研時表示,公司水處理產品領域,主要包括全屋淨水機(中央淨水機)、全屋軟水機(中央軟水機)、商用淨化飲水機、RO 膜反滲透淨水機、多路控制閥(家用控制閥)、複合材料壓力容器。
直銷模式以“開能”牌整機設備為主,同時提供 DSR 售後服務,提高用户粘性。國內經銷品牌以“奔泰”牌產品為主,國外經銷品牌主要為“Canature”牌和“Hydrotech”牌,在北美知名賣場銷售的品牌主要包括“Hydrotech”牌、 “NOVO”牌和“Rainfresh”牌。ODM/OEM 模式在國內與歐美均有。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.